Biodesix, Inc. (BDSX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$10.11
-0.15%
Mkt Cap $154.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $25.73M | $28.75M | +11.77% | -$1.05 | -$0.49 | +53.33% | — | — |
| Q4 2025 Nov 3, 2025 | $26.25M | $21.77M | -17.07% | -$1.60 | -$1.16 | +27.50% | — | — |
| Q3 2025 Aug 7, 2025 | $18.47M | $20.02M | +8.40% | -$1.40 | -$1.60 | -14.29% | — | — |
| Q2 2025 May 13, 2025 | $22.57M | $17.96M | -20.42% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q1 2025 Mar 3, 2025 | $20.32M | $20.43M | +0.54% | -$0.07 | -$0.06 | +14.29% | — | — |
| Q4 2024 Nov 1, 2024 | $19.83M | $18.15M | -8.48% | -$0.08 | -$0.07 | +12.50% | — | — |
| Q3 2024 Aug 7, 2024 | $16.21M | $17.93M | +10.58% | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2024 May 8, 2024 | $14.18M | $14.82M | +4.50% | -$0.15 | -$0.14 | +6.67% | — | — |
| Q1 2024 Mar 1, 2024 | $15.61M | $14.67M | -6.03% | -$0.11 | -$0.10 | +9.09% | — | — |
| Q4 2023 Nov 7, 2023 | $15.60M | $13.49M | -13.52% | -$0.15 | -$0.12 | +20.00% | — | — |
| Q3 2023 Aug 7, 2023 | $11.67M | $11.87M | +1.73% | -$0.21 | -$0.17 | +19.05% | — | — |
| Q2 2023 May 11, 2023 | $8.70M | $9.06M | +4.09% | -$0.26 | -$0.24 | +7.69% | — | — |
| Q1 2023 Mar 6, 2023 | $10.77M | $9.61M | -10.80% | -$0.26 | -$0.28 | -7.69% | — | — |
| Q4 2022 Nov 3, 2022 | $10.15M | $11.11M | +9.38% | -$0.32 | -$0.34 | -6.25% | — | — |
| Q3 2022 Aug 4, 2022 | $8.83M | $10.95M | +24.08% | -$0.47 | -$0.40 | +14.89% | — | — |
| Q2 2022 May 11, 2022 | $6.47M | $6.55M | +1.26% | -$0.38 | -$0.50 | -31.58% | — | — |
| Q1 2022 Mar 14, 2022 | $7.29M | $7.22M | -0.88% | -$0.50 | -$0.49 | +2.00% | — | — |
| Q4 2021 Nov 15, 2021 | $7.53M | $6.53M | -13.27% | -$0.50 | -$0.50 | +0.00% | — | — |
| Q3 2021 Aug 10, 2021 | $21.14M | $11.88M | -43.78% | -$0.31 | -$0.41 | -32.26% | — | — |
| Q2 2021 May 11, 2021 | $28.02M | $28.87M | +3.03% | -$0.13 | -$0.23 | -76.92% | — | — |